| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9956516 | International Journal of Cardiology | 2005 | 4 Pages |
Abstract
MetS-associated CHD prevalence in women aged 35-54 years is almost the same as in the control, whereas in women aged 55-74 and in men aged 35-54 or 55-74, this prevalence is about 2-fold that of the control. Endogenous estrogen may play a role in suppressing the pro-atherosclerotic effects of MetS-related risk factors, but further studies are needed for a more certain conclusion.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Wenjing Tong, Hong Lai, Chunyan Yang, Shiquan Ren, Shupeng Dai, Shenghan Lai,